Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Stiolto savings coupons?Ramelteon mechanism of action?Ketoconazole price in kenya?Why is spravato so expensive?Asmanex hfa 100 mcg inhaler price?
See the DrugPatentWatch profile for Mounjaro
Mounjaro (tirzepatide) was first approved for use in the United States on May 13, 2022, which is why it is commonly described as becoming available in 2022 shortly after approval.
People use “availability date” to refer to one of these milestones: - FDA approval date (the product can then be marketed in the U.S.) - First commercial shipment/launch date to pharmacies - Availability in other countries (dates differ by regulator and market) If you tell me the country (or whether you mean FDA approval vs. first pharmacy fill), I can pin down the exact “availability” definition you want.
Availability can change over time due to: - Supply constraints (which affected when patients could reliably get fills) - Expansion to additional indications, doses, or treatment settings Those details depend on the specific time period you care about.
For market and patent-related timelines tied to branded medicines, DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/
Other Questions About Mounjaro :